Insider Shareholders with Direct Ownership of Annexon, Inc. (ANNX)
This section provides a comprehensive overview of the insiders with direct ownership of Annexon, Inc. (ANNX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Annexon, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Douglas Love
PRESIDENT AND CEO |
345,493 | 42,455 | 310,570 $1.62 Million | 20 |
Oct 30, 2024
Added 10.4%
|
|
Michael Overdorf
EVP & CHIEF BUSINESS OFFICER |
79,850 | 6,707 | 94,622 $494,873 | 10 |
Jul 15, 2024
Reduced 0.82%
|
|
Dean Richard Artis
EVP & CHIEF SCIENTIFIC OFFICER |
39,000 | 0 | 89,329 $467,190 | 1 |
Feb 16, 2024
Added 30.39%
|
|
Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER |
91,850 | 20,471 | 86,468 $452,227 | 16 |
Jul 15, 2024
Reduced 1.26%
|
|
Ted Yednock
EVP & CHIEF INNOVATION OFFICER |
112,773 | 79,293 | 71,365 $373,238 | 14 |
Oct 15, 2024
Reduced 7.04%
|
|
Jamie Dananberg
CHIEF MEDICAL OFFICER |
39,000 | 0 | 39,000 $203,970 | 1 |
Feb 16, 2024
Added 50.0%
|
| 25,600 | 0 | 25,600 $133,888 | 8 |
Dec 02, 2024
Added 11.11%
|
|
|
Larry Mattheakis
EVP & Chief Scientific Officer |
21,876 | 0 | 17,188 $89,893 | 2 |
Jul 11, 2022
Added 21.43%
|
|
Sanjay Keswani
EVP & Chief Medical Officer |
16,495 | 3,995 | 12,500 $65,375 | 3 |
Feb 11, 2022
Added 50.0%
|